Fusaro M - Search Results

1

Clinical relevance and future perspective of fractures in patients with chronic kidney disease.

Fusaro M, Cannata-Andía JB, Nickolas TL, Plebani M, Mereu MC, Aghi A, Gallieni M. Fusaro M, et al. Kidney Int. 2018 May;93(5):1248. doi: 10.1016/j.kint.2018.02.012. Kidney Int. 2018. PMID: 29680025 Free article. No abstract available.

2

Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.

Fusaro M, Munaretto G, Spinello M, Rebeschini M, Amici G, Gallieni M, Piccoli A. Fusaro M, et al. J Nephrol. 2005 Jan-Feb;18(1):72-9. J Nephrol. 2005. PMID: 15772926

3

Management of secondary hyperparathyroidism in uremic patients: the role of the new vitamin D analogs.

Brancaccio D, Cozzolino M, Galassi A, Chiarelli G, Butti A, Bellasi A, Rocca-Rey L, Volpi A, Anelli A, Zoni U, Fusaro M, Brambilla C, Missaglia E, Crovetto C, Russo M, Longhini C, Provenzano R, Incalcaterra F, Cerasola G, Li Vecchi M, Gallieni M. Brancaccio D, et al. Among authors: fusaro m. J Nephrol. 2007 Jan-Feb;20(1):3-9. J Nephrol. 2007. PMID: 17347966 Review.

4

Vertebral fractures in dialysis: Endocrinological disruption of the bone-kidney axis.

Fusaro M, D'Angelo A, Scalzo G, Gallieni M, Giannini S, Guglielmi G. Fusaro M, et al. J Endocrinol Invest. 2010 May;33(5):347-52. doi: 10.1007/BF03346598. J Endocrinol Invest. 2010. PMID: 20534970 Review.

5

Plasma anti-Xa monitoring for low-molecular-weight heparins in patients with chronic kidney disease.

Gallieni M, Martini A, Granata A, Fusaro M. Gallieni M, et al. Among authors: fusaro m. Clin Pharmacokinet. 2010 Nov;49(11):773-4. doi: 10.2165/11534810-000000000-00000. Clin Pharmacokinet. 2010. PMID: 20923250 No abstract available.

6

Warfarin and heterotopic ossification: good, bad or ugly?

Gallieni M, Martini A, Fusaro M. Gallieni M, et al. Among authors: fusaro m. Spinal Cord. 2011 Mar;49(3):483; author reply 484. doi: 10.1038/sc.2010.141. Epub 2010 Oct 12. Spinal Cord. 2011. PMID: 20938450 No abstract available.

7

Vitamin K, bone fractures, and vascular calcifications in chronic kidney disease: an important but poorly studied relationship.

Fusaro M, Crepaldi G, Maggi S, Galli F, D'Angelo A, Calò L, Giannini S, Miozzo D, Gallieni M. Fusaro M, et al. J Endocrinol Invest. 2011 Apr;34(4):317-23. doi: 10.1007/BF03347093. Epub 2010 Nov 16. J Endocrinol Invest. 2011. PMID: 21088475 Review.

8

Bleeding, vertebral fractures and vascular calcifications in patients treated with warfarin: hope for lower risks with alternative therapies.

Fusaro M, Crepaldi G, Maggi S, D'Angelo A, Calo L, Miozzo D, Fornasieri A, Gallieni M. Fusaro M, et al. Curr Vasc Pharmacol. 2011 Nov;9(6):763-9. doi: 10.2174/157016111797484134. Curr Vasc Pharmacol. 2011. PMID: 21623708 Review.

9

Treatment with calcimimetic (cinacalcet) alters epoetin dosage requirements in dialysis patients: preliminary report.

Fusaro M, D'Angelo A, Naso A, Frigo AC, Miozzo D, Gallieni M, Calò LA. Fusaro M, et al. Ren Fail. 2011;33(7):732-5. doi: 10.3109/0886022X.2011.589937. Epub 2011 Jun 15. Ren Fail. 2011. PMID: 21671845 Free article.

10

Vitamin K, vertebral fractures, vascular calcifications, and mortality: VItamin K Italian (VIKI) dialysis study.

Fusaro M, Noale M, Viola V, Galli F, Tripepi G, Vajente N, Plebani M, Zaninotto M, Guglielmi G, Miotto D, Dalle Carbonare L, D'Angelo A, Naso A, Grimaldi C, Miozzo D, Giannini S, Gallieni M; VItamin K Italian (VIKI) Dialysis Study Investigators. Fusaro M, et al. J Bone Miner Res. 2012 Nov;27(11):2271-8. doi: 10.1002/jbmr.1677. J Bone Miner Res. 2012. PMID: 22692665 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

373 results

Search Page

Filters